New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study
Future Medicinal Chemistry · 2023-03 · 15 (5) · 405-419
DOI: 10.4155/fmc-2022-0306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, online erschienen am 04.04.2023. Verfasst von Muhammad Taha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute for Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi …. Hauptthemen laut MEDLINE: Heterocyclic Compounds, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute for Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, 31441, Saudi Arabia.
- Department of Chemistry, Hazara University, Mansehra, Khyber Pakhtunkhwa, 21300, Pakistan.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, 52571, Kingdom of Saudi Arabia.
- University Center for Research & Development (UCRD), Chandigarh University,Gharuan, Punjab, 140413, India.
- H. E. J. Research Institute of Chemistry, International Center for Chemical & Biological Sciences, University of Karachi, Karachi, Pakistan.
- Atta-ur-Rahman Institute for Natural Product Discovery (AuRIns), Universiti Teknologi MARA Cawangan Selangor Kampus Puncak Alam, Bandar Puncak Alam, Selangor D. E., 42300, Malaysia.
ORCID-Profile: Muhammad Taha, Fazal Rahim, Sridevi Chigurupati, Khalid Mohammed Khan, Syahrul Imran, Syed Adnan Ali Shah, Nizam Uddin
Zitieren
APA
Taha, M., Rahim, F., Hayat, S., Chigurupati, S., Khan, K. M., Imran, S., Ali Shah, S. A., Uddin, N., Felemban, S. G., & Venugopal, V. (2023). New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study. Future Medicinal Chemistry, 15(5), 405-419. https://doi.org/10.4155/fmc-2022-0306
Vancouver
Taha M, Rahim F, Hayat S, Chigurupati S, Khan KM, Imran S, et al. New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study. Future Medicinal Chemistry. 2023;15(5):405-419. doi:10.4155/fmc-2022-0306
BibTeX
@article{Taha2023,
author = {Taha, Muhammad and Rahim, Fazal and Hayat, Shawkat and Chigurupati, Sridevi and Khan, Khalid Mohammed and Imran, Syahrul and Ali Shah, Syed Adnan and Uddin, Nizam and Felemban, Shatha Ghazi and Venugopal, Vijayan},
title = {New pyrrolopyridine-based Thiazolotriazoles As Diabetics Inhibitors: Enzymatic Kinetics and In Silico Study},
journal = {Future Medicinal Chemistry},
year = {2023},
volume = {15},
number = {5},
pages = {405--419},
doi = {10.4155/fmc-2022-0306}
}
EUVIMED